Is it a commissioned work?

(0) 讚！ | 北冥俊远

Broke 10!!

(0) 讚！ | Brandon Motley

The corresponding author can be moved to another position so that the first author will be automatically displayed as the first author

(0) 讚！ | 无击又蕊

Is the corresponding author automatically considered the first author when submitting a manuscript to Cancer Treatment Reviews? If they are not the same person, how should this be adjusted? Thank you!

(0) 讚！ | 无冬甲午

Submission interface fails to verify the PDF. It always fails to build the PDF. I tried using several different browsers, but it still doesn't work. Does anyone know how to solve this?

(0) 讚！ | 孤云永顺

Hello, could you please provide detailed information on the submission status changes? Thank you.
seuzsl 2015-04-07 posted: Research direction: tumor; Topic selected in October 2014 (systematic review and meta-analysis), writing intermittently; submitted on January 24, 2015; major revision on March 4, 2015, with three reviewers providing many comments, leading to difficult modifications; revised on April 6, 2015; accepted on April 7, 2015

(0) 讚！ | Evangeline Broad

One word, rise. Embracing the increase with joy. With this momentum, breaking through 10 points in the future seems likely! I am in Anhui, can I post an article, satisfied

(0) 讚！ | 凌霄高洁

Does this magazine accept self-submitted meta-analyses, or do they only accept commissioned articles?

(0) 讚！ | 水月天生

Review speed: 2.0 | Submission acceptance rate: 75.0 Experience sharing: writing a systematic review and meta-analysis takes a long time

(0) 讚！ | 仙灵梦月

System review and meta analysis for a long time.

(0) 讚！ | Anonymous

Topic selected in October 2014 (systematic review and meta-analysis), written intermittently. Submitted on January 24, 2015, major revision on March 4, 2015, with three reviewers providing many suggestions. Difficult revisions were made. Revised on April 6, 2015, and accepted on April 7, 2015

(0) 讚！ | Ingram Stella

Too many submissions, no reason to reject them

(0) 讚！ | 凌霄高洁

The quality of the journal IF has been improving year by year. It is expected to surpass 7 points this year, and whether it can reach 10 points in the future depends on the editorial direction. The number of submissions has been gradually increasing, with a sharp increase in the number of articles published this year. The quality of articles is self-evident, and the requirements are also increasing year by year. Although it is currently a mid-level journal in the field of oncology, its ranking may be further improved in the future. Review articles are required to be broad and deep, with novel and insightful content, and their own clinical perspective

(0) 讚！ | 凌霄高洁

Review speed: 6.0 | Submission acceptance rate: 25.0
Sharing of experience: It is a comprehensive journal, not easy to submit articles

(0) 讚！ | 凌霄高洁